Peptonic Medical (publ) today announced that the company has signed a contract amendment with Orion Corporation in Finland. The amendment concerns Peptonic’s Moisturizing V Cleanser for the Finnish market where the product will be sold under Orion’s own brand Femisan®️.
Orion Corporation has been selling Peptonic’s gel for the treatment of vaginal atrophy under the brand Femisan®️ Vital since spring 2019. Since Orion mainly sell through physical pharmacies, sales have been negatively impacted during the pandemic. However, Orion again sees upward trends in the market and now expands its intimate range with Peptonic’s intimate wash, in Sweden sold under the name VagiVital®️ Moisturizing V Cleanser.
– We are of course very pleased that Orion wants to expand their collaboration with Peptonic. This is an important confirmation that our work to broaden the portfolio increases our attractiveness. More international partners are important for Peptonic’s further expansion, the increased partnership with Orion gives us increased credibility in dialogues with potential partners in other markets, says Erik Sundquist, CEO of Peptonic Medical.
An initial order equivalent to ca 13,000 units has been placed by Orion and will be delivered during the first quarter 2022.
This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 03-11-2021 16:30 CET.
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
About Peptonic Medical AB
Peptonic Medical AB (publ) is an innovative medtech company that conducts research, development and sales of medical devices and lifestyle products in the field of women’s health. Peptonic launched its first product, VagiVital®️ Active Gel against vaginal atrophy, in July 2018. In April 2021, VagiVital®️Moisturizing V Cleanser, was launched, a moisturizing and preventive intimate wash. The company was founded in 2009 and the share has been traded on Spotlight (www.spotlightstockmarket.com) in Stockholm since 2014.
Since August 2020, Lune Group Oy Ltd. has been a wholly owned subsidiary of Peptonic Medical. The company was founded in 2005 with the purpose to lead a light-hearted menstrual revolution in positive spirit via patented menstrual cups. The company is now evolving into leading the way in sustainable, intimate well-being.
In October 2021, all assets of Israeli company Common Sense Ltd were acquired. Common Sense has developed unique and patented self-tests to accurately diagnose bacterial vaginosis and amniotic fluid leakage respectively.